- Accesswire•3 days agoSHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Breaches of Fiduciary Duty by the Board of Advaxis, Inc. - ADXS
NEW YORK, NY / ACCESSWIRE / September 28, 2016 / Levi & Korsinsky announces it has commenced an investigation of Advaxis, Inc. (NASDAQ: ADXS) concerning possible breaches of fiduciary duty by the board ...
- GlobeNewswire•5 days agoAdvaxis’ Lm Technology Immunotherapies to be Showcased in Three Poster Presentations at SITC Annual Meeting
PRINCETON, N.J., Sept. 26, 2016-- Advaxis, Inc., a clinical stage biotechnology company developing cancer immunotherapies, today announced three poster presentations have been accepted by the Society for ...
- GlobeNewswire•12 days ago
PRINCETON, N.J., Sept. 19, 2016-- Advaxis, Inc., a clinical stage biotechnology company developing cancer immunotherapies, today announced that Robert Petit, Ph.D., executive vice president and chief scientific ...
Advaxis, Inc. (ADXS)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
|Bid||9.27 x 1700|
|Ask||11.15 x 300|
|Day's Range||10.14 - 10.77|
|52wk Range||5.21 - 16.30|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-5.60|
|Avg Vol (3m)||1,091,885|
|Dividend & Yield||N/A (N/A)|